Neuendorfstraße 15A, 16761 Hennigsdorf
03302 205650

Public Funding

Recently funded projects:

Peptidase-Antibody – Programm zur Förderung von Forschung, Innovation und Technologien (ProFIT Brandenburg), Nr. 8016982, 8016983

The main goal of the project is the development and characterization of the novel peptidase inhibitor Procizumab. Within the scope of the project, we develop a GMP cell line of Procizumab and characterize the antibody with different preclinical and biochemical methods. In addition, we develop immunoassays to detect the peptidase and Procizumab in plasma samples.

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help. Privacy Policy / Datenschutzerklärung | Imprint / Impressum

Select an option to continue

Your selection was saved!

More information


To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set. Borlabs Cookie already set a necessary cookie.

You can change your cookie setting here anytime: Privacy Policy / Datenschutzerklärung. Imprint / Impressum